SCIEX Biopharma meeting (Day 1) - Gene therapy, vaccines and oligonucleotides
This online event has been designed for our customers and brings together opinion leaders, top scientists and industry innovators to share their research in the biopharma field.
The technologies presented will be CE and LC-MS.
Agenda:
10:00–10:10 Welcome and introduction
- Steve Lock, SCIEX
10:10–10:35 Use of LC-MS in process analytical testing as part of development of a continuous manufacturing workflow
- Daniel Myatt / Ronan Gough, CPI
10:35–11:00 Tips and tricks for biotherapeutics characterization by peptide mapping
- Giulia Calloni, SCIEX
11:00–11:25 Developing methods for SEC-MS and IEX-MS for the analysis of biotherapeutics
- Sarah Nguyen, Strasbourg University
11:25–11:35 Break
11:35–12:00 The power of CZE analysis for characterization of NANOBODY® molecules
- Dries Dejaegere, Sanofi
12:00–12:25 Multi-capillary gel electrophoresis to increase throughput for the purity analysis of biotherapeutic proteins
- Theresa Merlino, The Janssen Pharmaceutical Companies of Johnson & Johnson
12:25–12:50 A disruptive approach to the characterization of mAb charge variants during biopharmaceutical process development
- Greg Adams, FUJIFILM
12:50–13:00 Wrap-up and Q&A
Presenter: Steve Lock, PhD (Snr. Marketing and Market Development Manager, Biopharma, EMEAI, SCIEX)
Steve obtained his PhD in Physical Organic Chemistry from the University College of Swansea in 1993 and is a chartered chemist and a member of the Royal Society of Chemistry. He has worked for SCIEX in various technical roles for over 20 years and has presented at over 80 international meetings around the world. He currently works closely with customers in the biopharmaceutical industry. Steve is also currently an Adjunct Professor at the University of Pannonia.
SCIEX - agenda day 1.jpg
